Verona Pharma PLC ADR
$86.78
(as of Jun 10, 4:00 PM EST)
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
Ticker Information for Verona Pharma PLC ADR
Stock Price
$86.78
Ticker Symbol
VRNA
Exchange
NASDAQ
Industry Information for Verona Pharma PLC ADR
Sector
Healthcare
Industry
Biotechnology
Company Description for Verona Pharma PLC ADR
Verona Pharma plc, a biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company offers Ohtuvayre, a dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that combines bronchodilator and non-steroidal anti-inflammatory effects for the maintenance treatment of chronic obstructive pulmonary disease, as well as cystic fibrosis and asthma. Verona Pharma plc was incorporated in 2005 and is headquartered in London, the United Kingdom.
Fundamentals for Verona Pharma PLC ADR
Market Capitalization
$9,689,163,776
EBITDA
$-133,641,000
Dividends per Share
P/E Ratio
Forward P/E Ratio
476.19
Earnings per Share
$-2.16
Earnings per Share Estimate Next Year
Profit Margin
-138.31%
Shares Outstanding
85,018,096
Percent Owned by Insiders
35.10%
Percent Owned by Institutions
86.56%
52-Week High
52-Week Low
Technical Indicators for Verona Pharma PLC ADR
Analyst Ratings for Verona Pharma PLC ADR
Strong Buy
7
Buy
3
Hold
0
Sell
0
Strong Sell
0